How To Spot a 100% Winner
It wasn’t long ago that I highlighted Planet Labs as a stock with the potential to blast off. At the time it was sitting at $1.90 per share.
Fast forward to the present and Planet Labs has soared well above $4 per share and is now posting gains of over 100%.
So what was it that revealed the hallmarks of a stock about to pop? » Read more about: How To Spot a 100% Winner »
Read More
Market Commentary: 2 Top AI Stocks To Capitalize On $1.8 Trillion Market In 2030
According to Grand View Research, the AI market is forecast to hit $1.8 Trillion by 2030. We’ll be surprised if that estimate is not eclipsed. In the past few weeks alone, the exponential growth of AI applications has been evident, including:
Read More
Alert: Fund Manager of Decade Bets $107.6M on 1 Stock
Investment Alert: Buy CMC Under $45/share
Disclaimer: Investment Alerts have a medium to long-term time horizon. These do not constitute financial advice and you should contact a financial advisor before deciding whether it is appropriate for your individual circumstances.
The big names get trotted out on CNBC and Bloomberg.
» Read more about: Alert: Fund Manager of Decade Bets $107.6M on 1 Stock »
Read More
Alert: 1 Warren Buffett Stock Down 65% You’ll Regret Not Buying
Investment Alert: Buy Snowflake Under $140 Per Share
Disclaimer: Investment Alerts have a medium to long-term time horizon. These do not constitute financial advice and you should contact a financial advisor before deciding whether it is appropriate for your individual circumstances.
Snowflake is a rare pre-IPO company that won the approval of Warren Buffett.
» Read more about: Alert: 1 Warren Buffett Stock Down 65% You’ll Regret Not Buying »
Read More
1 Organ Transplant Disruptor to Buy on the Dip
TransMedics (NASDAQ:TMDX) is an innovative biotechnology company that may well have the potential to disrupt the $11 billion organ transplant industry.
The company’s unique organ care system technology protects and monitors donor organs before they are transplanted into patients, resulting in improved organ health and outcomes. TransMedics also provides logistical services,
» Read more about: 1 Organ Transplant Disruptor to Buy on the Dip »
Read MoreThe Ivy
The $1 Trillion Buyback Boom, Who’s Spending Most to Boost Their Stock?
In February 2025 alone, corporate America saw an explosion of stock buybacks. More than 160 companies announced fresh repurchase plans—more than double the previous month’s tally. But the real story isn’t just the sheer volume; it’s who is leading the charge.
Goldman Sachs projects that S&P 500 buybacks will hit a record-breaking $1 trillion in 2025,
» Read more about: The $1 Trillion Buyback Boom, Who’s Spending Most to Boost Their Stock? »
Read MoreThe Spotlight
Spotlight: Turn $15k Into $1,000 Every Year
When we first spotlighted Verizon, it had a yield that approached 8% but after its recent move higher, it still offers a handsome yield of over 6.4%.
That’s more than enough to turn a $15,000 investment into an annual payout of $1,000+, assuming the dividend stays in place, but will it?
Here’s what you need to know about Verizon and its potential to pay a steady income stream for the foreseeable future.
» Read more about: Spotlight: Turn $15k Into $1,000 Every Year »
Read MoreThe Daily
TikTok beats trade war: Trump’s push to make the app legal again in US
It’s also been noted that a big ByteDance shareholder, the multi-billionaire Jeffrey Yass, was a major donor to the Trump campaign and that ByteDance’s chief executive Shou Chew was invited to sit on the dais at the inauguration, alongside former presidents and Trump family members.
Loading
US Congress passed the legislation ordering TikTok to either be sold or shut down because of concerns that the addictive app could be used by China to manipulate American public opinion by pushing misinformation,
» Read more about: TikTok beats trade war: Trump’s push to make the app legal again in US »